Detalhe da pesquisa
1.
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
Ann Hematol
; 94(8): 1347-56, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975975